Hepatic Lesion Clinical Trial
Official title:
iBEAM-Based Superb Micro-vascular Imaging for Evaluation of Hepatic Lesions
Superb Micro-vascular Imaging (SMI) based on the iBeam platform is used to evaluate the blood supply of solid tumors. Compared with color Doppler technology, the sensitivity, accuracy and consistency of the ability of SMI to display blood flow are evaluated. Thus, the investigators will use Superb-Microvascular imaging (SMI, Toshiba, Japan) for diagnosing hepatic lesions, which enable to detect slow micro vascular flow inside the tumor
To evaluate the diagnostic accuracy of SMI (primary outcome) when applying on the hepatic lesion. Each US findings during exam for patients with hepatic lesion were recorded by radiologist. Sample size calculation according to the primary outcome. ;